Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
Clinical trial NCT05176964 · UNKNOWN
Trial details
- NCT number
- NCT05176964
- Sponsor
- Fujian Medical University Union Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-31
- Primary completion
- 2024-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.